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Abstract
Rheumatoid arthritis (RA) is an autoimmune disease with a moderately strong genetic component.
Previous linkage and candidate gene studies have identified several regions that predispose to RA,
including the HLA-DRB1  and  PTPN22. We conducted genome-wide linkage analysis with 128
affected individuals from 60 families in a Canadian cohort that were genotyped using the Illumina
linkage panel and genome-wide association analysis with 158 affected individuals from the same
cohort that were genotyped using the Affymetrix 100 K platform. Multipoint nonparametric linkage
scan revealed three linkage peaks with LOD scores greater than 1.5. We also identified 13
significantly associated SNPs at the genome-wide level of 0.05 after Bonferroni adjustment for
multiple testing. Several of the significantly associated SNPs are located close to previously
identified linkage regions, but not in the linkage peaks identified in the same cohort. We could not
replicate association with HLA-DRB1 and PTPN22. Our results indicate that high coverage and
sufficient sample size are crucial for the success of genome-wide association studies.
Background
Rheumatoid arthritis (RA) is a complex autoimmune
genetic disorder in which the immune system attacks nor-
mal tissues as if they were invading pathogens. Twin and
family studies have suggested that the heritability of RA is
~60%. A well established RA susceptibility locus is the
HLA region located on chromosome 6p, which is esti-
mated to account for one-third of the genetic component
of RA etiology. Apart from the HLA region, a number of
other chromosomal regions have been replicated among
various genome-wide linkage scans in which the leading
regions include chromosome 1p13, 1q41–43, 6q16, 16p,
and 18q [1].
Linkage analysis has low power to detect genetic variants
that confer modest disease risks. For complex diseases
such as RA, tests of genetic association with the disease
may be more effective. Genetic association analyses have
led to the identification of PTPN22 [2], a gene that has
been replicated in many subsequent studies. Additional
susceptibility loci for RA that have been implicated by
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association analyses include PADI4,  SLC22A4,  RUNX1,
and CTLA4.
In this investigation, we performed genome-wide linkage
and association analyses of the Canadian Rheumatoid
Arthritis Genetic Study (CRAGS) data made available to
Genetic Analysis Workshop 15 participants. We seek to
identify genetic variants that predispose to RA and to char-
acterize their genetic contributions.
Methods
Data sets and initial data quality checking
The CRAGS provided two data sets. The first data set
includes 60 families (128 affected individuals) that were
genotyped using the Illumina linkage panel on 5429 SNPs
across 22 autosomal chromosomes. The second data set
includes 158 affected individuals (78 affected sib pairs
(ASPs) and one affected avuncular pair) that were geno-
typed using the Affymetrix 100 K platform on 113,237
SNPs across 22 autosomal chromosomes. Among the
113,237 SNPs, a total of 87,181 SNPs had >85% geno-
types completed, and exhibited a minor allele frequency
(MAF) of >0.05. The 87,181 SNPs that passed the initial
quality control had an average MAF of 0.247 and genotyp-
ing success rate of 96.8%.
Test of Hardy-Weinberg equilibrium in the presence of 
disease association
Assessing Hardy-Weinberg equilibrium (HWE) is often an
important step for checking the quality of genotype data.
The standard test of HWE assumes that the genotypes are
randomly sampled from the general population. However,
in the CRAGS, all individuals are affected. As a result, when
a marker is associated with the disease, the corresponding
genotypes may no longer be a random sample. Assessing
departure from HWE in the presence of disease association
is particularly important for genome-wide association stud-
ies in which the disease variants are either directly geno-
typed or are in linkage disequilibrium (LD) with the
genotyped markers. Analysis using the standard HWE test
might result in many rejections, and perhaps, some of the
rejected markers are in LD with the disease variants. Here
we develop a likelihood framework that allows the assess-
ment of departure from HWE while taking into account
potential association with the disease.
Assume a homogeneous sample of ASPs is collected and
genotyped at a diallelic marker with two alleles A and a
(with frequencies p and q, respectively). Let g ∈ {0, 1, 2}
represent the number of allele A, and Pg be the corre-
sponding genotype frequency. Under HWE, the geno-
type frequencies in the general population are P0 = q2, P1
= 2pq, and P2 = p2, respectively. For an ASP with geno-
types  g1  and  g2, the retrospective likelihood is
, where rg is the genotype relative risk of genotype g com-
pared with genotype 0. When HWE is assumed, the param-
eters to be estimated are {r1, r2, p}; when departure from
HWE is allowed, the parameters to be estimated are {r1, r2,
P1, P2}. Table 1 lists the joint genotype probability for a sib
pair under the null and the alternative models, respectively.
For a sample of ASPs, the overall likelihood of the data, L,
is simply the product of the likelihood for each ASP. We can
test for residual departure from HWE using a likelihood
ratio statistic T = 2[ln( 1) - ln( 0)], where  1 and  0 are
the likelihoods maximized under the alternative and the
null models, respectively. Under the null hypothesis of
HWE, T is approximately distributed as a χ2 distribution
with one degree of freedom. This test assesses departure
from HWE after adjusting for possible association with the
disease, therefore minimizing the chance that an important
marker is flagged as problematic.
Linkage and association analysis
We performed genome-wide, nonparametric multipoint
linkage analysis using the SPAIR statistic [3] as imple-
mented in MERLIN [4] on the 60 families that were geno-
typed using the Illumina linkage panel. The SPAIR statistic
combines information from pairs of affected individuals
and can detect regions of excess IBD sharing.
We performed single-marker association analysis using
LAMP [5,6], which uses a maximum-likelihood model to
extract information on genetic association from samples
of unrelated individuals, sibships, and larger pedigrees.
Briefly, the program estimates the disease-SNP haplotype
frequencies and three penetrances using all available data
by maximizing the likelihood of the marker data condi-
tional on the disease phenotypes. A likelihood ratio test
with approximately two degrees of freedom is constructed
by comparing the likelihood maximized under the alter-
native model, which allows for LD between the disease
and SNP loci, with the likelihood maximized under the
null model that assumes linkage equilibrium. We
assumed a fixed disease prevalence of 0.8%. Different dis-
ease prevalence changed parameter estimates slightly, but
did not appear to affect the overall ranking of SNPs.
Results
Our multipoint nonparametric linkage analysis revealed
three linkage signals at a LOD score threshold of 1.5, cor-
responding to a -log10(p-value) > 2.37 (Figure 1). These
linkage peaks are on chromosome 12 (LOD = 1.89 at 123
cM, asymptotic p-value = 0.002), chromosome 6 (LOD =
1.83 at 161.7 cM, asymptotic p-value = 0.002), and chro-
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mosome 9 (LOD = 1.69 at 141 cM, asymptotic p-value =
0.003). We did not observe evidence of linkage in the HLA
region, despite the fact that approximately one-third of
the total genetic contribution in RA is attributed to genes
in the HLA region. Because the Affymetrix 100 K platform
includes a denser set of SNPs in the HLA region and more
ASPs in the CRAGS were genotyped, we also conducted
nonparametric linkage analysis on chromosome 6 with
the Affymetrix SNPs. The analysis was conducted using
MERLIN [4], in which LD between SNPs was modeled by
considering haplotypes within clusters of tightly linked
markers. We obtained results similar to those from the
Illumina SNPs, suggesting that the lack of linkage evi-
dence is probably due to the limited sample size of the
CRAGS.
Among the 87,181 SNPs that were genotyped by the
Affymetrix 100 K platform and passed initial data quality
checking, 145 of them had a p-value < 0.001 using our test
of HWE. These SNPs were excluded from subsequent asso-
ciation analysis because LAMP assumes HWE at the tested
SNP in the general population. For the remaining 87,036
SNPs, we did single-marker association analysis using
LAMP (Figure 1). We corrected for multiple testing using
the Bonferroni criterion and controlled the family-wise
error rate at αgenome = 0.05. We identified 13 significantly
associated SNPs at the genome-wide level, but none of
them fell in linkage peaks identified using the 60 families
(Table 2).
The most strongly associated SNP is rs10492477, located
at 13q21. This SNP maps to the PCDH9  gene, which
belongs to the protocadherin gene family, a subfamily of
the cadherin superfamily. PCDH9  is predominantly
expressed in brain, but is also expressed in hairy cell leuke-
mia cells. Hairy cell leukemia can be responsible for pol-
yarthritis due to immunity-drive inflammation, which
can precede or follow the clinical onset of leukemic symp-
toms and usually presents as RA [7]. PCDH9 has not been
reported as a RA susceptibility locus, suggesting it is a new
candidate gene.
The next most strongly associated SNP is SNP_A-
1732768, located at 142.8 Mb on chromosome 2. This
SNP is ~15 Mb away from the linkage region identified
through linkage analysis in Caucasian families in the
North American Rheumatoid Arthritis Consortium [8]. In
addition, rs4834009 (chromosome 4, 126.3 Mb),
rs10520893 (chromosome 5, 23.7 Mb), and rs10509272
(chromosome 10, 67.8 Mb), are all within ~15 Mb of the
linkage regions identified by Amos et al. [8]. Although not
reaching genome-wide significance, several other SNPs
showed trend of association, including SNPs on chromo-
somes 6, 8, 11, 12, 16, 17, and 20.
Table 1: Joint genotype probability for a sib pair (genotypes are unordered)
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Unexpectedly, we did not observe significant association
between RA and PTPN22, despite that the association with
PTPN22 has been replicated extensively. Further examina-
tion of the data revealed that among the 42 SNPs that
were examined by the HapMap, only four of them were
included in the Affymetrix 100 K array set. Surprisingly,
we did not observe evidence of association between RA
and the HLA complex either. Among the 102 SNPs were
genotyped in the HLA region, 85 passed our data quality
checking, and the most strongly associated SNP had a p-
value of 0.05. A recent study of the extended MHC region
identified 6338 SNPs [9], whereas 5 only 1.6% of them
are included in the Affymetrix 100 K array set. Because
association analysis depends critically on the degree of LD
between the tested marker and the unobserved disease
locus, it is indeed not surprising that given the limited
coverage of the HLA region, the current data did not sup-
port evidence of association.
Conclusion
We conducted genome-wide linkage analysis using SNPs
genotyped by the Illumina linkage panel and genome-
wide association analysis using SNPs genotyped by the
Affymetrix 100 K platform on a set of affected relative
pairs of RA in CRAGS. Multipoint nonparametric linkage
analysis identified three linkage peaks with maximum
LOD score greater than 1.5. Our single marker association
analysis showed strong evidence of association on chro-
mosomes 1, 2, 4, 5, 7, 9, 10, 11, 13, 15, and 18. Several
significantly associated SNPs locate at or close to the pre-
viously detected RA linkage regions, but not in the linkage
peaks identified in the CRAGS.
Genome-wide linkage and association analysis Figure 1
Genome-wide linkage and association analysis. The solid curve is the -log10(p-value) of the multipoint LOD score from 
MERLIN. The gray line is the -log10(p-value) of the likelihood ratio test of association from LAMP. SNPs that are significantly 
associated with RA after Bonferroni adjustment are circled.BMC Proceedings 2007, 1(Suppl 1):S19 http://www.biomedcentral.com/1753-6561/1/S1/S19
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For the well-known RA-susceptibility loci-HLA-DRB1 and
PTPN22-we did not find evidence of association. Further
examination of the data revealed that both regions are not
well covered by the Affymetrix 100 K platform. Another
possible reason is that the sample size available to this
investigation is limited. Although genome-wide associa-
tion is a promising approach to search susceptibility genes
for complex diseases, the success of this approach
depends critically on several factors, including the effect
size of the disease genes, LD around the disease loci, and
the sample size of the study. Our results indicate that
future genome-wide association studies should employ a
platform that has better coverage across the genome.
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